Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

6170 of 115125
Newswise: Small Mutations Identified through Deep DNA Sequencing for AML and MDS

Small Mutations Identified through Deep DNA Sequencing for AML and MDS

Rutgers Cancer Institute of New Jersey

Deep DNA sequencing analysis conducted by Rutgers Cancer Institute of New Jersey investigators examining genomic differences within tumors for prediction of disease relapse in certain hematologic malignancies has identified small mutations. These may help further guide treatment decision making for patients.

Channels: All Journal News, Blood, Cancer, Genetics, Medical Meetings,

Released:
9-Dec-2019 5:05 PM EST
Open in New Tab
Comment
Embargo will expire:
12-Dec-2019 2:00 PM EST
Released to reporters:
9-Dec-2019 4:30 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 12-Dec-2019 2:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
Newswise: Retrospective Analysis Shows Proton Therapy Well Tolerated in Patients Undergoing Breast Conserving Surgery

Retrospective Analysis Shows Proton Therapy Well Tolerated in Patients Undergoing Breast Conserving Surgery

Rutgers Cancer Institute of New Jersey

Investigators at Rutgers Cancer Institute of New Jersey conducted a retrospective review of patients treated with proton therapy following breast-conserving surgery and found acceptable toxicity rates along with good-to-excellent patient-reported cosmetic outcomes.

Channels: All Journal News, Cancer, Healthcare, Surgery, Women's Health, Medical Meetings,

Released:
9-Dec-2019 4:20 PM EST
Open in New Tab
Comment
Research Results
Newswise: Giving Common Antibiotic Before Radiation May Help Body Fight Cancer
  • Embargo expired:
    9-Dec-2019 4:00 PM EST

Giving Common Antibiotic Before Radiation May Help Body Fight Cancer

Perelman School of Medicine at the University of Pennsylvania

The antibiotic vancomycin alters the gut microbiome in a way that can help prime the immune system to more effectively attack tumor cells after radiation therapy

Channels: All Journal News, Cancer, Clinical Trials, Microbiome, Grant Funded News,

Released:
9-Dec-2019 12:00 AM EST
Open in New Tab
Comment
Research Results
Newswise: Yale Cancer Center study suggests new approaches needed to manage ibrutinib-related toxicities in CLL patients
  • Embargo expired:
    9-Dec-2019 3:45 PM EST

Yale Cancer Center study suggests new approaches needed to manage ibrutinib-related toxicities in CLL patients

Yale Cancer Center

New findings by Yale Cancer Center (YCC) and Smilow Cancer Hospital researchers show that as the use of the drug ibrutinib climbs in patients with chronic lymphocytic leukemia (CLL), so do the rates of patients who stop taking the drug.

Channels: All Journal News, Blood, Cancer, Clinical Trials, Pharmaceuticals, Medical Meetings,

Released:
9-Dec-2019 10:50 AM EST
Open in New Tab
Comment
Research Results
Newswise: Researchers identify ‘Achilles’ heel’ of drug-resistant superbug

Researchers identify ‘Achilles’ heel’ of drug-resistant superbug

University of Texas Health Science Center at Houston

Researchers at The University of Texas Health Science Center at Houston (UTHealth) have identified a protein that allows vancomycin-resistant enterococci to defy antibiotic treatment and immune system attacks. Their discovery opens the door for future treatment options in the fight against antibiotic resistance.

Channels: All Journal News, Drug Resistance, Healthcare, Immunology, Infectious Diseases, Microbiome, Pharmaceuticals, Grant Funded News,

Released:
9-Dec-2019 3:15 PM EST
Open in New Tab
Comment
Research Results
Newswise: Medical Errors Remain Problem 20 Years after Critical Report on Patient Safety

Medical Errors Remain Problem 20 Years after Critical Report on Patient Safety

Johns Hopkins University Carey Business School

Medical errors remain as vexing a problem, according to Bloomberg Distinguished Professor Kathleen Sutcliffe of Johns Hopkins University. She discusses the issue in her new book Still Not Safe: Patient Safety and the Middle-Managing of American Medicine, co-authored with Robert Wears.

Channels: All Journal News, Healthcare, In the Workplace, Patient Safety,

Released:
9-Dec-2019 2:55 PM EST
EXPERT AVAILABLE
Open in New Tab
Comment
Research Results
Newswise: CAR T-cell therapy effective for relapsed mantle cell lymphoma patients
  • Embargo expired:
    9-Dec-2019 2:45 PM EST

CAR T-cell therapy effective for relapsed mantle cell lymphoma patients

University of Texas M. D. Anderson Cancer Center

A one-year follow-up study revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric antigen receptor (CAR) .

Channels: All Journal News, Blood, Cancer, Healthcare, Pharmaceuticals,

Released:
4-Dec-2019 12:40 PM EST
Open in New Tab
Comment
Feature Expert
Newswise: Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patients with classic Hodgkin lymphoma, study finds
  • Embargo expired:
    9-Dec-2019 2:45 PM EST
Released:
26-Nov-2019 5:05 PM EST
Open in New Tab
Comment
Research Results
WFBH_color.jpg
Released:
9-Dec-2019 2:40 PM EST
Open in New Tab
Comment
Research Results

Showing results

6170 of 115125

Chat now!
1.29532